3rd International Symposium on Biology, Prevention, and Treatment of Toxicities After Transplantation and Cellular Therapy

This 3rd international Symposium will bring together a diverse group of experts and thought leaders in the fields of HCT, cellular therapies, and related medical subspecialties. Speakers will discuss current advances in the field, mechanisms of toxicities, symptom burden, and late effects after HCT and cellular therapies along with best practices to prevent and treat these complications.

This unique 2-day program will be comprised of sessions dedicated to a wide range of pre-clinical, translational, and clinical topics, including cellular therapies as a model of accelerated aging, CAR T cell-related toxicities, infectious complications, decision science, the role of the gut microbiome in toxicities, debates on how to diagnose and treat difficult complications such as transplant-associated thrombotic microangiopathy, and several keynote lectures from world experts.

Our symposium will help facilitate networking and multidisciplinary research collaborations. Additionally, attendees are invited to a special luncheon (space limited) and a networking/poster reception.

>> Who Should Attend

The target audience for this Symposium includes physicians, advanced practice providers (physician assistants and nurse practitioners), and nurses who treat or refer patients for hematopoietic cell transplantation or immune effector cell therapies (i.e., CAR T cells; tumor infiltrating lymphocytes, or T cell receptor therapy).

In-person or Virtual Registration Available: This Symposium will be available in-person at Memorial Sloan Kettering's Zuckerman Research Center in New York or virtually via Zoom. In-person attendees have the option to register to attend the special luncheon session as well as the networking/poster reception.

>> Special Luncheon Session (In-person Only)

Available to in-person attendees only, the focus of this optional luncheon session is on Improving Outcomes with Active Acute Leukemia Undergoing Transplant. Due to space, the luncheon is only available to 50 attendees and selection must be made during course registration. We do recommend early registration in order to secure your spot. Luncheon confirmation will be sent prior to the start of the Symposium.

>> Networking and Poster Reception (In-person Only)

In-person attendees are also invited to attend the networking reception, which will include an exciting poster session. This event will be held in the lobby of Zuckerman Research Center and RSVP is required. If you are interested in joining the reception, please be sure to select this as an option in your registration. Hors d'oeuvre and refreshments will be served.

>> Call for Abstracts (Submission Deadline: April 7)

We are pleased to invite the submission of abstracts for this Symposium. Abstracts will be selected on the basis of their scientific merit and content quality. Abstract submission is open to all, and we also highly encourage fellows, residents, pharmacists, and advanced practice providers to submit relevant abstracts in the area of biology, prevention, and treatment of toxicities after transplantation and cellular therapy. In addition, abstracts related to trials and/or clinical research in progress will be accepted.

The top five awarded abstracts will receive complimentary registration to the symposium. Abstracts can be submitted through the 'Abstract' tab above. Please do not register prior to receiving confirmation of acceptance.

• The submission deadline for abstracts is April 7, 2023.
• Notification of acceptance will be sent April 14, 2023.

1. Identify the mechanisms of the most common treatment-related toxicities after HCT and cellular therapy.
2. Discuss the best practices in the prevention and treatment of toxicities and symptom burden after HCT and cellular therapy.
3. Collaborate with a multidisciplinary group of colleagues to discuss, brainstorm, and plan future quality improvement and research efforts to reduce toxicities, improve the patient experience, and decrease non-relapse mortality.

Registration Fees (In-person or Virtual)

• Physicians (MDs, PhDs, PharmDs, and DOs)
  • Early Rate: $400
  • General Rate: $450
• Advanced Practice Providers
  • Early Rate: $300
  • General Rate: $350
• Residents, Fellows, Nurses, Data Managers, and Other Healthcare Providers
  • Early Rate: $225
  • General Rate: $275
• MSK Employees
  • Complimentary
• Industry Professionals*
  • Early Rate: n/a
  • General Rate: $775

*Industry professionals may attend MSK CME activities for their own education. Marketing, sales, and promotion of products and services is strictly prohibited at MSK CME activities. For more information, please visit our Help page.

Registration Discounts/Promotions

• EARLY RATE: Register by 11:59 pm EST on March 17, 2023 to receive a $50 off your total registration. Enter the promotion code TXEARLY23 during registration to take advantage of the early rate discount.
• A registration discount is available for MSK Alumni and MSK Cancer Alliance members to attend this Symposium. If you are a member of one of these groups, contact [email protected] for details.

Please note that after your payment has been processed, no further promotional discounts or adjustments will be made to your registration.

In-person Registration

Course registration includes continental breakfast, lunch, refreshment breaks, and an invitation to the Networking and Poster Reception on Friday evening. Please contact [email protected] at least one week prior to the course if you have any special dietary requests or require any specific accommodations.

While MSK requests that institutional guests are vaccinated against COVID-19, we are no longer requiring proof of vaccination. Additional details, including our current Health and Safety Protocols, can be accessed on our Visiting Us page. If you are not feeling well or exhibiting any symptoms of COVID-19, please refrain from attending an in-person event at MSK and contact [email protected] as soon as possible.

Virtual Registration

The virtual option for this program will be delivered through Zoom. Access details, including a link to Zoom and faculty disclosures, will be sent to virtual registrants via email prior to the start of the Symposium.

Cancellation Policy

If you wish to cancel your participation in this course, you must email [email protected] at least seven (7) days prior to the start of the course, and your refund will be subject to a $25 administrative fee if attending virtually or a $100 administrative fee if attending in-person. Cancellations or no-shows within seven (7) days of the course are not eligible for a refund. Please note that if it has been more than 120 days since payment was processed, a W9 form must be submitted in order process your refund and your refund will be issued in the form of a check payment. Refunds are not subject to tax. You may substitute another registrant in your place at any time by contacting [email protected] with the appropriate information.

MSK CME reserves the right to cancel or postpone any course due to unforeseen circumstances. In the unlikely event we must cancel or postpone this course, you will be notified via email from MSK CME ([email protected]). A full refund will be issued for your registration. MSK CME is not responsible for any related costs, charges, or expenses to participants, including fees incurred by airline/travel/lodging agencies.

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 14.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MSK Symposium Director

Sergio A. Giralt, MD
Deputy Division Head; Attending, Division of Hematologic Malignancies
Melvin Berlin Family Chair in Multiple Myeloma
Chief Medical Officer, MSK Direct
Bone Marrow Transplant and Cellular Therapy Services 
Department of Medicine  

MSK Symposium Co-Director

Michael Scordo, MD
Assistant Attending
Bone Marrow Transplant and Cellular Therapy Services 
Department of Medicine  


Symposium Planning Committee

Rafael F. Duarte, MD, PhD, FRCP
Head, Department of Hematology and Transplantation Programme, 
Hospital Universitario Puerta de Hierro Majadahonda;
Profesor Asociado de Hematología - Universidad Autónoma de Madrid
Madrid, Spain

Shahinaz Gadalla, MD, PhD
Senior Investigator, Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics 
National Cancer Institute, NIH
Bethesda, MD 

Vincent T. Ho, MD 
Clinical Director, Adult Hematopoeitic Stem Cell Transplantation 
Dana-Farber Cancer Institute
Boston, MA

Shernan Holtan, MD
Associate Professor of Medicine 
University of Minnesota 
Minneapolis, MN

Robert R. Jenq, MD
Associate Professor, Deputy Chair, Genomic Medicine
University of Texas MD Anderson Cancer Center 
Houston, TX

Karthik Nath, MBBS, PhD
Assistant Attending , Cellular Therapy Service
Memorial Sloan Kettering Cancer Center 
New York, NY 

Armin Rashidi, MD, PhD
Associate Professor
Fred Hutchinson Cancer Center 
Seattle, WA

Gabriela Rondon, MD
Professor, Department of Stem Cell Transplantation - Research, Division of Cancer Medicine
University of Texas MD Anderson Cancer Center 
Houston, TX

Melody Smith, MD, MS
Assistant Professor, Medicine 
Division of Blood and Marrow Transplantation and Cellular Therapy 
Stanford Medicine 
Stanford, CA

Anthony D. Sung, MD
Associate Professor of Medicine
Duke Blood Cancer Center 
Durham, NC

Anna Sureda, MD, PhD
Head of Department, Clinical Hematology Department
Institut Català d’Oncologia - Hospitalet
Barcelona, Spain

John Reid Wingard, MD 
Deputy Director, University of Florida Health Cancer Center
Director, Bone Marrow Transplant Program 
UF Health Cancer Center 
Gainesville, FL

William A. Wood, MD, MPH
Professor of Medicine
University of North Carolina School of Medicine 
Chapel Hill, NC

Gregory A. Yanik, MD
Professor, Pediatric Hematology/Oncology, Pediatrics, and Internal Medicine,
Medical Director, Bone Marrow, Medical School
University of Michigan Medicine 
Ann Arbor, MI

MSK Symposium Faculty 

Genovefa Papanicolaou, MD
Attending Physician
Infectious Disease Service 
Professor, Weill Cornell Medicine

Jonathan Peled, MD, PhD
Assistant Attending
Bone Marrow Transplant and Cellular Therapy Service

Jacob Glass, MD, PhD
Assistant Attending
Leukemia Service

Gunjan L. Shah, MD, MS
Assistant Attending
Bone Marrow Transplant and Cellular Therapy Service

Invited Symposium Faculty 

Lawrence A. David, MD, PhD  
Associate Professor, Molecular Genetics and Microbiology 
Duke University Schoool of Medicine
Durham, NC 

Mette Hazenberg, MD, PhD
Cinical Hematologist; Physician-Scientist; Group Leader, Immunologist
Amsterdam UMC and Sanquin Research
Amsterdam, The Netherlands 

Josh Hill, MD
Associate Professor, Vaccine and Infectious Disease and Clinical Research 
Fred Hutchinson Cancer Center
Seattle, WA

Shernan Holtan, MD
Associate Professor of Medicine 
University of Minnesota
Minneapolis, MN 

Jonathan Huggins, MD
Assistant Professor, Medicine and Infectious Diseases 
Duke University Schoool of Medicine
Durham, NC

Nandita Khera, MD, MPH
Professor, Medicine
Mayo Clinic Alix School of Medicine 
Phoenix, AZ

Marcela Maus, MD
Associate Professor, Medicine
Harvard Medical School 
Massachusetts General Hospital Cancer Center
Boston, MA

Laura Niedernhofer, MD, PhD
Director, Institute on the Biology of Aging and Metabolism
The University of Minnesota
Minneapolis, MN

Amanda Olson, MD
Associate Professor
Department of Stem Cell Tranplantation and Cellular Therapy
MD Anderson Cancer Center
Houston, TX

Samir Parekh, MD
Professor of Medicine
Mount Sinai
New York, NY

Pavan V. Reddy, MD
Director, Duncan Cancer Center 
Senior Associate Dean, Cancer Programs 
Baylor College of Medicine
Houston, TX 

Daniel Richardson, MD
Assistant Professor
The University of North Carolina
School of Medicine
Chapel Hill, NC 

Nirali N. Shah, MD, MHSc
Head, Hematologic Malignancies Section
National Cancer Institute, NIH 
Bethesda, MD

Noha Sharafeldin, MD, MSc, PhD
Assistant Professor
Division of Hematology & Oncology 
Institute for Cancer Outcomes and Survivorship 
The University of Alabama at Birmingham
Birmingham, AL

Robert Soiffer, MD
Chief, Division of Hematologic Malignancies 
Dana-Farber Cancer Institute
Boston, MA

Marion Subklewe, MD
Attending Physician
Head of Immunotherapy in Hematology
LMU University Hospital Munich
Munich, Germany

Mitigation of Relevant Financial Relationships

Memorial Sloan Kettering Cancer Center adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.

Memorial Sloan Kettering gratefully acknowledges the following organizations for providing educational grants for this live activity:

Actinium Pharmaceuticals, Inc.
Angiocrine Bioscience, Inc.
Novartis

Abstract Submission

The 3rd International Symposium on Biology, Prevention, and Treatment of Toxicities After Transplantation and Cellular Therapy invites the submission of abstract posters in the area of biology, prevention, and treatment of toxicities after transplantation and cellular therapy. In addition, abstracts related to trials and/or clinical research in progress will be accepted. Abstracts will be selected to be displayed during the symposium. 

Abstract submission deadline: Friday, April 7, 2023
Notification of acceptance will be provided by April 14, 2023.

Please do NOT register before submitting an abstract. Top 5 accepted authors will receive complimentary registration for this symposium. After you have been accepted, you will receive detailed instructions from MSK CME upon abstract approval.